Quick Answer
CorMedix Inc. reported Research And Development Expense of $19.33 million for the year ending 2025.
- CorMedix Inc. showed an increase of +390.4% in Research And Development Expense from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $248.2 thousand | Q3 2012: $255.7 thousand | Q1 2013: $255.0 thousand | Q2 2013: $380.2 thousand | Q3 2013: $750.8 thousand | Q1 2014: $353.0 thousand | Q2 2014: $171.9 thousand | Q3 2014: $292.7 thousand | Q1 2015: $1.2 thousand | Q2 2015: $1.8 thousand | Q3 2015: $1.8 thousand | Q4 2015: $1.5 thousand | Q1 2016: $2.09 million | Q2 2016: $2.77 million | Q3 2016: $6.84 million | Q4 2016: $4.0 thousand | Q1 2017: $4.92 million | Q2 2017: $5.09 million | Q3 2017: $6.01 million | Q1 2018: $8.28 million | Q2 2018: $6.60 million | Q3 2018: $8.29 million | Q1 2019: $2.87 million | Q2 2019: $2.98 million | Q3 2019: $2.52 million | Q1 2020: $2.47 million | Q2 2020: $5.69 million | Q3 2020: $2.93 million | Q1 2021: $2.64 million | Q2 2021: $2.52 million | Q3 2021: $4.74 million | Q1 2022: $2.29 million | Q2 2022: $3.21 million | Q3 2022: $2.34 million | Q1 2023: $3.41 million | Q2 2023: $4.79 million | Q3 2023: $2.66 million | Q1 2024: $837.4 thousand | Q2 2024: $651.0 thousand | Q3 2024: $727.1 thousand | Q1 2025: $3.19 million | Q2 2025: $2.44 million | Q3 2025: $5.10 million.
- Over the full 16 years of available data (2010 to 2025), CorMedix Inc.'s Research And Development Expense has grown by 251.9%.
- Historical annual values: Fiscal year 2025: $19.33 million | Fiscal year 2024: $3.94 million | Fiscal year 2023: $13.16 million | Fiscal year 2022: $10.68 million | Fiscal year 2021: $13.13 million | Fiscal year 2020: $13.38 million | Fiscal year 2019: $11.05 million | Fiscal year 2018: $18.82 million | Fiscal year 2017: $24.49 million | Fiscal year 2016: $15.74 million | Fiscal year 2015: $6.28 million | Fiscal year 2014: $1.32 million | Fiscal year 2013: $1.23 million | Fiscal year 2012: $1.14 million | Fiscal year 2011: $4.10 million | Fiscal year 2010: $5.49 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: